IL131496A0 - Modified retinoblastoma tumor suppressor proteins - Google Patents

Modified retinoblastoma tumor suppressor proteins

Info

Publication number
IL131496A0
IL131496A0 IL13149698A IL13149698A IL131496A0 IL 131496 A0 IL131496 A0 IL 131496A0 IL 13149698 A IL13149698 A IL 13149698A IL 13149698 A IL13149698 A IL 13149698A IL 131496 A0 IL131496 A0 IL 131496A0
Authority
IL
Israel
Prior art keywords
tumor suppressor
suppressor proteins
retinoblastoma tumor
modified retinoblastoma
modified
Prior art date
Application number
IL13149698A
Other languages
English (en)
Original Assignee
Univ Texas
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Baylor College Medicine filed Critical Univ Texas
Publication of IL131496A0 publication Critical patent/IL131496A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4736—Retinoblastoma protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13149698A 1997-02-20 1998-02-19 Modified retinoblastoma tumor suppressor proteins IL131496A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3811897P 1997-02-20 1997-02-20
PCT/US1998/003041 WO1998037091A2 (fr) 1997-02-20 1998-02-19 Proteines modifiees de suppression des retinoblastomes

Publications (1)

Publication Number Publication Date
IL131496A0 true IL131496A0 (en) 2001-01-28

Family

ID=21898180

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13149698A IL131496A0 (en) 1997-02-20 1998-02-19 Modified retinoblastoma tumor suppressor proteins

Country Status (8)

Country Link
EP (1) EP0975750A2 (fr)
JP (1) JP2001512325A (fr)
KR (1) KR20000075501A (fr)
CN (1) CN1259998A (fr)
AU (1) AU6657398A (fr)
CA (1) CA2281899A1 (fr)
IL (1) IL131496A0 (fr)
WO (1) WO1998037091A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110484623A (zh) * 2019-08-27 2019-11-22 深圳市宝安区妇幼保健院 一种rb1突变基因、引物、检测方法、试剂盒及应用
WO2021062389A2 (fr) * 2019-09-27 2021-04-01 Saint Leo University Peptide pour le traitement du cancer
WO2023173105A2 (fr) * 2022-03-10 2023-09-14 Saliogen Therapeutics, Inc. Système inducteur/répresseur de tétracycline et production de particules virales simplifiée

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496731A (en) * 1993-03-25 1996-03-05 Xu; Hong-Ji Broad-spectrum tumor suppressor genes, gene products and methods for tumor suppressor gene therapy
US5969120A (en) * 1993-09-03 1999-10-19 Research Development Foundation Mutants of the RB and P53 genes
AU7834994A (en) * 1993-09-13 1995-04-03 Canji, Inc. Therapeutic use of the retinoblastoma susceptibility gene product

Also Published As

Publication number Publication date
WO1998037091A2 (fr) 1998-08-27
KR20000075501A (ko) 2000-12-15
CN1259998A (zh) 2000-07-12
EP0975750A2 (fr) 2000-02-02
WO1998037091A3 (fr) 1998-11-05
JP2001512325A (ja) 2001-08-21
CA2281899A1 (fr) 1998-08-27
AU6657398A (en) 1998-09-09

Similar Documents

Publication Publication Date Title
GB9718463D0 (en) Biomolecules
ZA9710338B (en) Proteins
GB9719879D0 (en) Protein
GB9703681D0 (en) Protein complemention
EP1018551A4 (fr) Proteine megsine
GB9718110D0 (en) Peptides
ZA984322B (en) Sucrose-binding proteins
GB9700154D0 (en) Peptides
IL131496A0 (en) Modified retinoblastoma tumor suppressor proteins
GB9715064D0 (en) Protein expression
GB9828704D0 (en) Proteins
GB9816337D0 (en) Proteins
GB9720784D0 (en) Protein
EP0996457A4 (fr) Peptides liberateurs de f.s.h.
GB2330775B (en) Target
EP1127066A4 (fr) Proteines modifiees
AU6579698A (en) Human tumor suppressor
ZA971900B (en) Modified proteins
GB0320970D0 (en) Proteins
GB9816335D0 (en) Proteins
GB9816336D0 (en) Proteins
GB9707822D0 (en) Proteins
GB9707499D0 (en) Proteins
GB9700121D0 (en) Proteins
GB9703104D0 (en) Proteins